HumanOptics AG / Key word(s): Preliminary Results
Publication of inside information pursuant to Article 17 of Regulation (EU) No. 596/2014
Preliminary business figures 2019/2020: Effects of COVID 19 pandemic weigh on sales and earnings
Erlangen, 27 August 2020 - In the course of the ongoing annual financial statement work of HumanOptics AG (ISIN DE000A1MMCR6), one of the leading technology companies in the manufacture of high-quality implants for eye surgery, it is currently becoming apparent that the sales and earnings figures for the 2019/2020 financial year ended on 30 June 2020 will be below previous expectations.
According to preliminary and unaudited figures, HumanOptics AG ("Company") currently expects the following for the financial year 2019/2020
This development is mainly due to the economic consequences of the COVID-19 pandemic, which - despite short-time work and other measures taken to reduce personnel and material costs - had a significant impact on the second half of the year.
The final and complete business figures of HumanOptics AG for the financial year 2019/2020 ended 30 June 2020 are scheduled to be published in October 2020.
Information and derivations of the financial figures used can be found in the Annual Report 2018/2019 of HumanOptics AG (available on https://www.humanoptics.com/wp-content/uploads/2019/10/Geschaeftsbericht-2018-2019-HumanOptics-AG.pdf), in particular on page 34.
|Spardorfer Str. 150|
|Phone:||+49 (0)9131 - 50665-60|
|Fax:||+49 (0)9131 - 50665-93|
|Listed:||Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Stuttgart|
|EQS News ID:||1124433|
|End of Announcement||DGAP News Service|